Upcoming posts that have been written and are waiting to go live.
Not all data comes in perfectly. But that does not make it useless. Designing for partial compliance can lead to better inclusion, richer insight, and more realistic results.
Audit trails should not be noise. They should tell a clear story of what happened, when, and why. In digital trials, they are how the study proves it was run with care.
Apps might get more attention, but SMS still delivers. In digital trials, a simple text message can be the link that keeps participants engaged and on track.
Designing a protocol is more than science. Every clause becomes a digital task, workflow, or alert. And if those aren't mapped early, study tools start to buckle.
No sites, no binders, no physical visits. But fully virtual trials still need structure, support, and oversight. The work doesn't disappear - it just changes shape.
Participants rarely disengage all at once. It often starts slowly, in the middle stretch. This post explores how to spot it, how to respond, and how to design for it.
You don't set and forget a participant app. Real-world use reveals what works, what doesn't and what needs adjusting to keep engagement and data quality high.
95% compliance looks great until you realise it's the same symptom score repeated ten days in a row. High rates can hide low engagement if we don't ask how the data was really collected.
Language is not a finishing touch in digital trials. It is the interface between your study and its participants. And it shapes trust more than we realise.
The best digital trials are not just designed for the digitally fluent. They are built to include those who need the most support, not just those with the newest devices.
Reminders inform. Nudges shape behaviour. Smart trials use both, and know the difference.
Flexibility makes digital trials more human. But it only works when the system can bend without breaking.
Digital first does not mean digital only. Paper still has a quiet role in making trials more resilient, inclusive and human.
Not everything entered electronically is eSource. The true source is where the data is original, complete, and auditable.
In digital trials, clean data does not mean flawless data. It means data you can trust, track, and explain.
More data is not always better. Without clear purpose, volume creates noise, not insight.
Minimal datasets are not about collecting less. They are about collecting what truly matters to answer the research question.
Participants enter their data. Then it disappears. Showing them where it goes builds trust, care, and long-term engagement.
Digital tools for nutritional trials need more than structure. They need space to capture patterns, behaviours, and context.
Digital Phase 1 trials need more than technology. They need systems built for fast signals, real-time oversight, and safety-first design.
In Phase 3 trials, flexibility is not about lowering standards. It is about designing systems that adapt without breaking.
The trial may end, but the data journey continues. Post-market studies demand new ways of collecting meaningful, low-burden data.
